Impact of switching virologically suppressed, HIV-1-infected patients from twice-daily fixed-dose zidovudine/lamivudine to once-daily fixed-dose tenofovir disoproxil fumarate/emtricitabine.

Edwin DeJesus,Peter Ruane,Cheryl McDonald, Fernando Garcia, Shetal Sharma, Roberto Corales, Jayashree Ravishankar, Homayoun Khanlou,David Shamblaw,Janet Ecker,Ramin Ebrahimi,John Flaherty

HIV CLINICAL TRIALS（2008）

引用 32|浏览20

暂无评分

摘要

Patients switched to EFV + TDF/FTC maintained virologic suppression and the regimen was well tolerated. Patients reported increased satisfaction with treatment and fewer were bothered by side effects.

查看译文

关键词

AZT/3TC,TDF/FTC,treatment simplification

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要